4
Changes in Ownership
Celldex Therapeutics, Inc. Filed Acc 0001415889-24-015147
SVP AND CFO sold 35,000 shares at $34.05 ($1,191,775)
- SVP AND CFO acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Martin Samuel Bates SVP AND CFO | 2024-05-30 | Option exercise | +25,000 | $10.38 | $259,500 | 60,128 | D |
| Martin Samuel Bates SVP AND CFO | 2024-05-30 | Sale | −35,000 | $34.05 | $1,191,775 | 25,128 | D |
| Derivatives | |||||||
| Martin Samuel Bates SVP AND CFO | 2024-05-30 | Option exercise · Incentive Stock Option (Right to Buy) | −25,000 | 80,600 | D | ||
| Open-market sales · 35,000 sh · avg $34.05 · $1,191,775 | |||||||
Loading xslF345X05/form4-06032024_080645.xml…